UniProt ID | EPHA4_MOUSE | |
---|---|---|
UniProt AC | Q03137 | |
Protein Name | Ephrin type-A receptor 4 | |
Gene Name | Epha4 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 986 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein . Cell projection, axon . Cell projection, dendrite . Cell junction, synapse, postsynaptic cell membrane, postsynaptic density. Early endosome . Clustered upon activation and targeted to early endos |
|
Protein Description | Receptor tyrosine kinase which binds membrane-bound ephrin family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Highly promiscuous, it has the unique property among Eph receptors to bind and to be physiologically activated by both GPI-anchored ephrin-A and transmembrane ephrin-B ligands including EFNA1 and EFNB3. Upon activation by ephrin ligands, modulates cell morphology and integrin-dependent cell adhesion through regulation of the Rac, Rap and Rho GTPases activity. Plays an important role in the development of the nervous system controlling different steps of axonal guidance including the establishment of the corticospinal projections. May also control the segregation of motor and sensory axons during neuromuscular circuit development. In addition to its role in axonal guidance plays a role in synaptic plasticity. Activated by EFNA1 phosphorylates CDK5 at 'Tyr-15' which in turn phosphorylates NGEF regulating RHOA and dendritic spine morphogenesis. In the nervous system, plays also a role in repair after injury preventing axonal regeneration and in angiogenesis playing a role in central nervous system vascular formation. Additionally, its promiscuity makes it available to participate in a variety of cell-cell signaling regulating for instance the development of the thymic epithelium.. | |
Protein Sequence | MAGIFYFILFSFLFGICDAVTGSRVYPANEVTLLDSRSVQGELGWIASPLEGGWEEVSIMDEKNTPIRTYQVCNVMEASQNNWLRTDWITREGAQRVYIEIKFTLRDCNSLPGVMGTCKETFNLYYYESDNDKERFIRESQFGKIDTIAADESFTQVDIGDRIMKLNTEIRDVGPLSKKGFYLAFQDVGACIALVSVRVFYKKCPLTVRNLAQFPDTITGADTSSLVEVRGSCVNNSEEKDVPKMYCGADGEWLVPIGNCLCNAGHEEQNGECQACKIGYYKALSTDASCAKCPPHSYSVWEGATSCTCDRGFFRADNDAASMPCTRPPSAPLNLISNVNETSVNLEWSSPQNTGGRQDISYNVVCKKCGAGDPSKCRPCGSGVHYTPQQNGLKTTRVSITDLLAHTNYTFEIWAVNGVSKYNPSPDQSVSVTVTTNQAAPSSIALVQAKEVTRYSVALAWLEPDRPNGVILEYEVKYYEKDQNERSYRIVRTAARNTDIKGLNPLTSYVFHVRARTAAGYGDFSEPLEVTTNTVPSRIIGDGANSTVLLVSVSGSVVLVVILIAAFVISRRRSKYSKAKQEADEEKHLNQGVRTYVDPFTYEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRNPNSLKRTGSESSRPNTALLDPSSPEFSAVVSVGDWLQAIKMDRYKDNFTAAGYTTLEAVVHMSQDDLARIGITAITHQNKILSSVQAMRTQMQQMHGRMVPV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
140 | Phosphorylation | KERFIRESQFGKIDT HHHEEEHHHCCCCCE | 22.44 | 29899451 | |
153 | Phosphorylation | DTIAADESFTQVDIG CEEECCCCCEECCHH | 33.85 | 29899451 | |
177 | Phosphorylation | IRDVGPLSKKGFYLA EEECCCCCCCCEEEE | 35.14 | 23737553 | |
235 | N-linked_Glycosylation | EVRGSCVNNSEEKDV EEECCCCCCCCCCCC | 51.11 | - | |
340 | N-linked_Glycosylation | LNLISNVNETSVNLE CEEEECCCCCEEEEE | 51.59 | - | |
408 | N-linked_Glycosylation | TDLLAHTNYTFEIWA HHHHHHCCCEEEEEE | 24.79 | - | |
587 | Ubiquitination | KQEADEEKHLNQGVR HHHHHHHHHHHHHHH | 51.88 | 22790023 | |
595 | Phosphorylation | HLNQGVRTYVDPFTY HHHHHHHHCCCCCCC | 26.03 | 22817900 | |
596 | Phosphorylation | LNQGVRTYVDPFTYE HHHHHHHCCCCCCCC | 7.71 | 8622893 | |
601 | Phosphorylation | RTYVDPFTYEDPNQA HHCCCCCCCCCHHHH | 31.24 | - | |
602 | Phosphorylation | TYVDPFTYEDPNQAV HCCCCCCCCCHHHHH | 20.79 | 8622893 | |
654 | Phosphorylation | EICVAIKTLKAGYTD HEEEEEEEHHCCCCH | 27.64 | 18846507 | |
659 | Phosphorylation | IKTLKAGYTDKQRRD EEEHHCCCCHHHHHH | 19.34 | 18846507 | |
660 | Phosphorylation | KTLKAGYTDKQRRDF EEHHCCCCHHHHHHH | 35.48 | 22817900 | |
735 | Ubiquitination | RGIGSGMKYLSDMSY HCCCCCCHHHHCCCH | 46.71 | 22790023 | |
761 | Acetylation | VNSNLVCKVSDFGMS ECCCEEEEECCCCCC | 36.98 | 6569755 | |
779 | Phosphorylation | EDDPEAAYTTRGGKI CCCCCHHCCCCCCCC | 18.72 | 22499769 | |
780 | Phosphorylation | DDPEAAYTTRGGKIP CCCCHHCCCCCCCCC | 12.80 | 22499769 | |
781 | Phosphorylation | DPEAAYTTRGGKIPI CCCHHCCCCCCCCCC | 18.03 | 22499769 | |
887 | Phosphorylation | KLIRNPNSLKRTGSE HHHHCCCHHCCCCCC | 36.20 | 26824392 | |
893 | Phosphorylation | NSLKRTGSESSRPNT CHHCCCCCCCCCCCC | 33.42 | 25338131 | |
900 | Phosphorylation | SESSRPNTALLDPSS CCCCCCCCCCCCCCC | 22.74 | 25177544 | |
906 | Phosphorylation | NTALLDPSSPEFSAV CCCCCCCCCCCCCEE | 59.18 | 29899451 | |
928 | Phosphorylation | QAIKMDRYKDNFTAA HHHCHHHCCCCCCCC | 20.59 | 22817900 | |
947 | Phosphorylation | LEAVVHMSQDDLARI HHHEEECCHHHHHHH | 18.64 | 29899451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
596 | Y | Phosphorylation | Kinase | EPHA4 | Q03137 | GPS |
602 | Y | Phosphorylation | Kinase | EPHA4 | Q03137 | GPS |
779 | Y | Phosphorylation | Kinase | EPHA4 | Q03137 | PSP |
928 | Y | Phosphorylation | Kinase | EPHA4 | Q03137 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EPHA4_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EPHA4_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
VAPB_HUMAN | VAPB | physical | 18555774 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale identification and evolution indexing of tyrosinephosphorylation sites from murine brain."; Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.; J. Proteome Res. 7:311-318(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-596 AND TYR-602, ANDMASS SPECTROMETRY. | |
"A juxtamembrane autophosphorylation site in the Eph family receptortyrosine kinase, Sek, mediates high affinity interaction withp59fyn."; Ellis C., Kasmi F., Ganju P., Walls E., Panayotou G., Reith A.D.; Oncogene 12:1727-1736(1996). Cited for: PHOSPHORYLATION AT TYR-596 AND TYR-602, AND INTERACTION WITH FYN. |